Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor. [electronic resource]
Producer: 20140318Description: 466-71 p. digitalISSN:- 1399-3046
- Anemia, Hemolytic, Autoimmune -- etiology
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Calcineurin -- metabolism
- Cyclophosphamide -- therapeutic use
- Cyclosporine -- therapeutic use
- Everolimus
- Female
- Hemolysis
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunosuppression Therapy -- adverse effects
- Immunosuppressive Agents -- adverse effects
- Infant
- Intestines -- transplantation
- Liver Transplantation -- adverse effects
- Male
- Medical Records
- Nephrotic Syndrome -- etiology
- Pancreas Transplantation -- adverse effects
- Penicillins -- therapeutic use
- Plasmapheresis
- Retrospective Studies
- Rituximab
- Sirolimus -- analogs & derivatives
- Steroids -- therapeutic use
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Tacrolimus -- therapeutic use
- Transplantation -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.